Navigation Links
Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies
Date:4/19/2010

Preclinical research takes a giant step forward with two industry leading companies creating an integration breakthrough with toxicology software and study-scaled capsule filling device.

Greifensee, Zurich (PRWEB) April 19, 2010 -- The world-class preclinical software developer PDS Pathology Data System (PDS) and METTLER TOLEDO (MT), global manufacturer of weighing technology, announce a cooperative initiative to improve the security and accuracy of preclinical processes. The result of the collaboration is an integration of the powerful MT powder dosing system, Quantos and the PDS mission-critical software system, ToxData. The solution will provide significant efficiencies while increasing data security and assuring full regulatory compliance.

In making this historic announcement, Matthias Gietenbruch, Head of Automated Weighing and Dosing of MT explained, “Bringing the integration of Quantos and ToxData together in the preclinical laboratory is truly a landmark for efficiency and accuracy. We are pleased to forging this alliance with PDS. They have distinguished themselves as being customer-focused and leaders in innovative preclinical software solutions."

Reto Aerni, CEO of PDS, commented, “PDS has always taken pride in raising the bar in the preclinical space. The opportunity to work with METTLER TOLEDO in such an innovative project and provide our mutual customers a synergistic value that is simply unavailable anywhere else is exciting and representative of the best that both our companies stand for."

Quantos is a novel powder dosing system that provides unprecedented dose filling speed and accuracy in the preclinical lab. ToxData is a leading protocol-driven software system used for acquiring, measuring and reporting preclinical study data. Through the interface of the two systems, accurate work lists are sent to the dosing system and dose preparations are filled automatically without the labor intensive efforts normally associated with a manual process. This joint system automatically identifies and handles different target amounts, reducing the risk of false dosings. Capsules are uniquely specified in a way that confusions or misallocations are eliminated.

Complying with international quality standards-

Comprehensive documentation with all relevant data required by the authorities is reported. This integrated solution provides data security and full regulatory compliance as requested by the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA). This makes preclinical trials a quick and safe process. Both companies offer worldwide sales, service and support for preclinical trials.

Reducing errors and speeding up processes-

Preclinical trials are of high importance for today's pharmaceutical industry. In this strictly regulated process, no errors can be accepted. Accurate reporting is crucial, and yet time to market has to be as short as possible.
The integration of devices and systems such as Quantos and ToxData strengthen the process in many respects, including accuracy, safety, quality and efficiency.

About METTLER TOLEDO
METTLER TOLEDO is a leading global manufacturer of precision instruments. The Company is the world’s largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The Company also holds top-three market positions in several related analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the world’s largest manufacturer and marketer of metal detection systems used in production and packaging. Additional information about METTLER TOLEDO can be found at “www.mt.com.”

About PDS Pathology Data Systems
PDS has a thirty year history of providing preclinical software solutions to a very well-satisfied user base. With worldwide headquarters in Basel, Switzerland and New Jersey offices for North America user training, support and marketing, PDS provides a full product suite of software solutions through its integrated and modular systems, PathData for post mortem activities, ToxData for general toxicology and clinical pathology and ReproData for reproductive and teratology studies.
PDS software is used by 8 of the Top 10 pharmaceutical companies in the world and a global user base from small working groups to global multi-site organizations, CROs, crop protection companies and regulatory agencies. Because they are very flexible, modular and scalable multilingual systems, PDS software is ideally suited for a wide variety of users.

Contact Information
Mettler Toledo
Lars Mller, Product & Market Manager
Im Langacher, CH-8606 Greifensee/ZH
Switzerland
+41 44 944 27 02

PDS - Europe, Asia, Australia
Reto Aerni, CEO
Lettenstr. 9, CH-6343 Rotkreuz/ZG
Switzerland
+41 41 511 2810

PDS - North America
Arthur C Karakos, Sr VP, Global Marketing
100 Stierli Ct, Ste 105
Mount Arlington, NJ 07856 USA
1 973 398 2800

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3874804.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Process Safety and Thermal Hazard Analysis Fall Webinar Series presented by METTLER TOLEDO
2. Maximize Data Analysis with METTLER TOLEDO FBRM
3. METTLER TOLEDO and AAPS: Utilization of Process Modeling and Advanced Process Control in QbD based Drug Development and Manufacturing
4. METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis (SPPS)
5. Martin Madaus Joins Mettler Toledo Board of Directors
6. IMPAC Medical Systems and Aperio to Develop Integrated Solution for Anatomic Pathology
7. Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner
8. ARUP Laboratories Partners With Pathology Service Associates
9. Boveran Diagnostics, Inc. Announces Planned Acquisition of New York-Based Pathology Lab: Sophora Diagnostic Lab, Inc.
10. James L. Wittliff, Ph.D., FACB, to Present Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System at the Association for Molecular Pathology Conference, October 30
11. Cancer, Heart Disease, Stroke, Diabetes, Chronic Pain and Depression Share a Major Pathology Factor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies
(Date:2/6/2016)... McLean, VA (PRWEB) , ... February 06, 2016 , ... ... enrichment session, cost-free, for middle and high school teachers on Wednesday February 10, 2016. ... be held at the Smithsonian-Mason School of Conservation, located at 1500 Remount Road in ...
(Date:2/5/2016)... 2016  In the pharmaceutical industry the medical affairs ... launch activities including the identification and engagement of key ... especially high in the oncology therapeutic area where most ... the Role of Medical Affairs in Oncology Launch Excellence ... therapies find better ways to utilize medical affairs to ...
(Date:2/5/2016)... 2016 Australian-US drug discovery and development company, Novogen ... of a new Chairman, Mr John O,Connor , and ... James Garner , has also been formally ... Acting CEO, Mr Iain Ross , will resume his ... James Garner , has also been formally appointed to ...
(Date:2/4/2016)... Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today that Edward Lanphier , Sangamo,s president and ... progress of Sangamo,s ZFP Therapeutic ® development programs ... 2:40 pm ET on Thursday, February 11, 2016, at ... Conference. The conference is being held in ...
Breaking Biology Technology:
(Date:2/3/2016)... India , February 3, 2016 ... the new market research report "Automated Fingerprint Identification System ... Search, Latent Search), Application (Banking & Finance, Government, Healthcare, ... published by MarketsandMarkets, the market is expected to be ... CAGR of 21.0% between 2015 and 2020. The transformation ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
Breaking Biology News(10 mins):